CLINICAL_TRIALS
trial_result
· 2019-10-01
Clinical Trial Update: Predischarge Initiation of Ivabradine in the Management of Heart Failure (PRIME-HF) [Phase 4]
Summary
Phase 4 trial update on predischarge initiation of ivabradine for heart failure; completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Duke University | Conditions: Heart Failure | Phase 4 | Status: COMPLETED | Results posted: 2019-10-01